David A. Wolk

Neurology
3400 Civic Center Boulevard
South Pavilion, 2nd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 390 publications

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

Journal: Neurology
Published: August 26, 2026

Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients With Frontotemporal Lobar Degeneration.

Association Between Postmortem Pathologic Burden and the Rate of Clinical Progression in Patients With Frontotemporal Lobar Degeneration.

Journal: Neurology
Published: July 21, 2026

Predicting Risk of Cognitive Impairment With Alzheimer Disease Blood Biomarkers.

Predicting Risk of Cognitive Impairment With Alzheimer Disease Blood Biomarkers.

Journal: JAMA
Published: July 15, 2026

Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease.

Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease.

Journal: JAMA
Published: July 12, 2026

Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment.

Depression and anxiety modify cognitive concerns associated with amyloid and early clinical impairment.

Journal: Neuropsychology
Published: June 15, 2026

Reply: Cerebrovascular contributions to the 'vulnerable' medial temporal lobe T-N phenotype.

Reply: Cerebrovascular contributions to the 'vulnerable' medial temporal lobe T-N phenotype.

Journal: Brain : a journal of neurology
Published: June 08, 2026

Progress towards a biotypic biomarker profile for amyotrophic lateral sclerosis-frontotemporal spectrum disorders.

Progress towards a biotypic biomarker profile for amyotrophic lateral sclerosis-frontotemporal spectrum disorders.

Journal: Brain : a journal of neurology
Published: April 13, 2026

Patterns and Trends of Glucose-Lowering Therapy in Alzheimer's Disease and Related Dementias.

Patterns and Trends of Glucose-Lowering Therapy in Alzheimer's Disease and Related Dementias.

Journal: Diabetes, obesity & metabolism
Published: February 18, 2026

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences
Published: February 06, 2026

An imaging biomarker to detect non-glucogenic shift in brain energy metabolism in Alzheimer's disease.

An imaging biomarker to detect non-glucogenic shift in brain energy metabolism in Alzheimer's disease.

Journal: Journal of translational medicine
Published: January 28, 2026

Vulnerability of anterior medial temporal lobe subregions to early tau-related neurodegeneration in Alzheimer's disease: Converging evidence from tau-PET and plasma p-tau217.

Vulnerability of anterior medial temporal lobe subregions to early tau-related neurodegeneration in Alzheimer's disease: Converging evidence from tau-PET and plasma p-tau217.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 28, 2026

Idiotypic-susceptible Alzheimer's disease: a clinically relevant, neurofibrillary tangle subtype.

Idiotypic-susceptible Alzheimer's disease: a clinically relevant, neurofibrillary tangle subtype.

Journal: Acta neuropathologica
Published: January 28, 2026
Showing 1-12 of 390

Last Updated: 09/26/2026